Taylor & Francis

Expert Opinion on Therapeutic Patents Template

Write in a clean editor, then format for Expert Opinion on Therapeutic Patents in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Expert Opinion on Therapeutic Patents format

Expert Opinion on Therapeutic Patents is a peer-reviewed journal published by Taylor & Francis, covering Intellectual Property and Patents, Diverse Scientific and Economic Studies, Legal Cases and Commentary.

PublisherTaylor & Francis
Reference styleAuthor–year (Chicago, T&F)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Expert Opinion on Therapeutic Patents 12 (3): 45–58.

Formats any DOI in Expert Opinion on Therapeutic Patents style. No sign-up.

Publishes research inIntellectual Property and Patents Diverse Scientific and Economic Studies Legal Cases and Commentary Receptor Mechanisms and Signaling Monoclonal and Polyclonal Antibodies Research
ISSN1354-3776
Citation impact (2-yr)5.13
h-index103
i10-index1,546
Total citations69,809
Top institutions publishing hereWeatherford College
Journal websiteinformahealthcare.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Expert Opinion on Therapeutic Patents per year

119
2014
120
2015
128
2016
77
2017
71
2018
77
2019
81
2020
68
2021
50
2022
52
2023
85
2024
63
2025

Citation impact of Expert Opinion on Therapeutic Patents by publication year

3.8K
2014
3.7K
2015
5.2K
2016
2.5K
2017
3.5K
2018
3.3K
2019
3.3K
2020
1.9K
2021
966
2022
706
2023
671
2024
195
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Expert Opinion on Therapeutic Patents

Carbonic anhydrase inhibitors and their therapeutic potential

Claudiu T. Supuran, Andrea Scozzafava · 1 May 2000

Carbonic anhydrases (CAs, EC 4.2.1.1) are wide-spread zinc enzymes, present in archaeo- and eubacteria, algae, green plants and animals. Within these organisms CAs are encoded by three distinct, evolutionarily unrelated gene families: the α-CA, the β-CA and the γ-CA families, respectively. These enzymes are very efficient catalysts for the reversible hydration of CO2 to bicarbonate;…

Schiff bases in medicinal chemistry: a patent review (2010-2015)

Abdul Hameed, Mariya al‐Rashida, Maliha Uroos et al. · 24 Oct 2016

INTRODUCTION: Schiff bases are synthetically accessible and structurally diverse compounds, typically obtained by facile condensation between an aldehyde, or a ketone with primary amines. Schiff bases contain an azomethine (-C = N-) linkage that stitches together two or more biologically active aromatic/heterocyclic scaffolds to form various molecular hybrids with interesting biological properties. Schiff bases are…

Solid lipid nanoparticles: a review on recent perspectives and patents

Rishi Paliwal, Shivani Rai Paliwal, Rameshroo Kenwat et al. · 31 Jan 2020

Introduction: Solid lipid nanoparticles (SLNs) are solid core lipid nanocarriers, which can hold both hydrophilic and hydrophobic drugs. They can be made up of biocompatible ingredients and therefore are one of the preferred choices for drug delivery. Surface modifications of SLNs may further provide unique features to them like mucoadhesiveness or targeting capability.Areas covered: In…

Antiglaucoma carbonic anhydrase inhibitors: a patent review

Emanuela Masini, Fabrizio Carta, Andrea Scozzafava et al. · 30 Apr 2013

INTRODUCTION: Glaucoma is one of the major causes of blindness, affecting together with age-related macular degeneration > 70 million people worldwide. One of the therapeutic options for its management is based on the inhibition of the metalloenyme carbonic anhydrase (CA, EC 4.2.1.1). CA inhibitors (CAIs) diminish intraocular pressure (IOP) by reducing the rate of bicarbonate…

Expert Opinion on Therapeutic Patents template — frequently asked questions

How do I write a paper in the Expert Opinion on Therapeutic Patents format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Expert Opinion on Therapeutic Patents template. When you export, DocuGuru compiles the paper into the official Taylor & Francis format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Expert Opinion on Therapeutic Patents use?
Expert Opinion on Therapeutic Patents uses Author–year (Chicago, T&F) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Expert Opinion on Therapeutic Patents 12 (3): 45–58.
Do I need to know LaTeX to submit to Expert Opinion on Therapeutic Patents?
No. DocuGuru generates the interact LaTeX class and compiles the PDF for you in the background, so you get a Taylor & Francis-ready Expert Opinion on Therapeutic Patents document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Expert Opinion on Therapeutic Patents template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Expert Opinion on Therapeutic Patents format with correct headings, figures, tables, and author–year citations.
Who publishes Expert Opinion on Therapeutic Patents?
Expert Opinion on Therapeutic Patents is a multidisciplinary journal published by Taylor & Francis. DocuGuru's Expert Opinion on Therapeutic Patents template matches Taylor & Francis's official submission format.
Can I export a submission-ready Expert Opinion on Therapeutic Patents PDF?
Yes — DocuGuru produces a PDF built with the official Expert Opinion on Therapeutic Patents template (the interact class) that is ready to submit to Taylor & Francis, together with the matching LaTeX source files.
How much does the Expert Opinion on Therapeutic Patents template cost?
You can start writing in the Expert Opinion on Therapeutic Patents template for free. Exporting the final submission-ready Expert Opinion on Therapeutic Patents PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Expert Opinion on Therapeutic Patents template